Nobivac Parvo-C

Nobivac Parvo-C

Injectable live vaccine for dogs containing attenuated canine parvovirus.


Nobivac Parvo-C

Nobivac Parvo-C contains live, attenuated, freeze dried, virus vaccine containing canine parvovirus, grown in cell line tissue culture. Each vial contains a single dose for reconstitution prior to use. For active immunisation of dogs against canine parvovirus. Protects against CPV type 2, type 2a and type 2b. it is recommended that puppies are vaccinated with Nobivac DHPPi + Nobivac Lepto 2 twice, 2-4 weeks apart (or Nobivac L4 four weeks apart), with the final vaccination at an age of more than 10 weeks as a basic course of vaccination. If however prior to starting that basic vaccination course protection against CPV is required, an additional vaccination with Nobivac Parvo-C is advised.

For uses, dosage, contra-indications and warnings please consult product leaflet. Use medicines responsibly.

Active Ingredients
A live attenuated freeze-dried vaccine containing canine parvovirus.

For active immunisation of puppies against canine parvovirus infection.

  • The puppy programme can be completed from a minimum of 10 weeks of age.
  • Nobivac Parvo-C has been shown to protect against canine parvovirus for at least three years.
  • Onset of immunity is one week after administration.
  • Nobivac Parvo-C can be used in pregnant bitches.

Reconstitute each single dose vial of the vaccine with one vial of Nobivac diluent or Nobivac Lepto I and administer by subcutaneous injection. Each of the Nobivac vaccines fits into a larger overall vaccination programme. The individual’s age, health (including maternal immunity) and local environmental conditions should be considered in the formulation of a vaccination programme.

Packaging Quantities

Clear, Glass Type I (PhEur) single vials with halogenobutyl rubber stopper, closed with a colour-coded aluminium cap. Cartons containing 10 or 50 vials.

MSD Product